Transcat (TRNS) Posts Earnings Results, Beats Estimates By $0.09 EPS

Transcat (NASDAQ:TRNS) posted its quarterly earnings results on Tuesday. The scientific and technical instruments company reported $0.35 EPS for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.09, Fidelity Earnings reports. Transcat had a net margin of 4.37% and a return on equity of 12.05%.

Shares of Transcat stock opened at $24.11 on Wednesday. The company has a current ratio of 2.16, a quick ratio of 1.45 and a debt-to-equity ratio of 0.40. Transcat has a 1 year low of $16.90 and a 1 year high of $25.35. The stock has a market cap of $173.16 million, a price-to-earnings ratio of 33.96, a price-to-earnings-growth ratio of 2.99 and a beta of 0.90.

A number of institutional investors have recently modified their holdings of the business. Wells Fargo & Company MN grew its holdings in Transcat by 7.6% during the 1st quarter. Wells Fargo & Company MN now owns 7,703 shares of the scientific and technical instruments company’s stock worth $177,000 after acquiring an additional 547 shares in the last quarter. Hancock Whitney Corp grew its holdings in Transcat by 7.3% during the 1st quarter. Hancock Whitney Corp now owns 11,005 shares of the scientific and technical instruments company’s stock worth $253,000 after acquiring an additional 750 shares in the last quarter. Marshall Wace North America L.P. grew its holdings in Transcat by 157.5% during the 1st quarter. Marshall Wace North America L.P. now owns 1,545 shares of the scientific and technical instruments company’s stock worth $36,000 after acquiring an additional 945 shares in the last quarter. O Shaughnessy Asset Management LLC grew its holdings in Transcat by 7.2% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 15,038 shares of the scientific and technical instruments company’s stock worth $286,000 after acquiring an additional 1,007 shares in the last quarter. Finally, Morgan Stanley bought a new position in Transcat during the 1st quarter worth about $36,000. Institutional investors own 58.67% of the company’s stock.

A number of research analysts have recently commented on the stock. Zacks Investment Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a report on Thursday, April 11th. ValuEngine upgraded shares of Transcat from a “hold” rating to a “buy” rating in a report on Monday, February 4th.

COPYRIGHT VIOLATION WARNING: This report was reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://www.themarketsdaily.com/2019/05/22/transcat-trns-posts-earnings-results-beats-estimates-by-0-09-eps.html.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More: What is insider trading?

Earnings History for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.